Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

Clinical trial NCT03806426 · UNKNOWN

Trial details

NCT number: NCT03806426
Sponsor: S.L.A. Pharma AG
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Familial Adenomatous Polyposis

Start date: 2018-12-05
Primary completion: 2024-06-30
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.